The epidemiology of cervical carcinogenesis

Cancer

Volumn 76, Issue 10 S, 1995, Pages 1888-1901

  Schiffman, Mark H ^a   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

carcinoma; cervix; epidemiology; human papillomavirus infection

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CONFERENCE PAPER; FEMALE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX NEOPLASMS; FEMALE; HUMAN; MALE; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; RISK FACTORS; SMOKING; TUMOR VIRUS INFECTIONS;

EID: 0028810148     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H     Document Type: Article

References (165)

1. Estimates of the worldwide frequency of eighteen major cancers in 1985
2. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adeno‐squamous cell carcinoma of the cervix?
3. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem
4. Impact of the Bethesda System
5. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses
6. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns
7. High prevalence of papillomavirus‐associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia
8. Basaloid and warty carcinomas of the vulva: distinctive types of squamous cell carcinoma frequently associated with human papillomavirus
9. Papillomaviruses
10. Human papillomaviruses and cervical neoplasia
11. Serological assays for the detection of HPV antibodies
12. A virus‐like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16
13. Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells
14. Human papillomavirus infections in women with and without abnormal cervical cytology
15. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women
16. Validation of HPV hybridization assays: correlation of FISH, dot blot, and PCR with Southern blot
17. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection
18. Polymerase chain reaction‐based methods for the detection of human papillomavirus DNA
19. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types
20. Environment and disease: association or causation?
21. HPV and cervical cancer: review of case‐control and cohort studies
22. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
23. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites
24. Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri
25. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
26. Human papillomavirus infection of the female genital tract: correlation of HPV DNA with cytologic, colposcopic, and natural history findings
27. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study
28. Prospective follow‐up of genital HPV infections: survival analysis of the HPV typing data
29. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence
30. Molecular biology of cervical cancer and its precursors
31. The carcinogenic effect of papilloma virus on the tarred skin of rabbits. I. Description of the phenomenon
32. High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus
33. Human papillomavirus type 16 DNA‐induced malignant transformation of NIH 3T3 cells
34. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata
35. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro
36. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations
37. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms
38. The human papilloma virus‐16 E7 oncoprotein is able to bind to the retinoblastoma gene product
39. Association of human papillomavirus types 16 and 18 E6 proteins with p53
40. The causal link between human papillomavirus and invasive cervical cancer: a population‐based case‐control study in Columbia and Spain
41. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia
42. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults
43. Determinants of genital human papillomavirus infection in young women
44. Determinants of genital human papillomavirus infection in low‐income women in Washington, D.C
45. The absence of genital human papillomavirus DNA in virginal women
46. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections
47. Human papillomavirus DNA in CO2 laser‐generated plume of smoke and its consequences to the surgeon
48. Human papillomavirus DNA associated with foreskins of normal newborns
49. Rarity of cesarean delivery in cases of juvenile‐onset respiratory papillomatosis
50. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears
51. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependent
52. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors
53. High prevalence rate of human papillomavirus infection and association with abnormal Papanicolaou smears in sexually active adolescents
54. Comparison of virapap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer
55. Epidemiology of cervical human papillomaviruses
56. Determinants of genital human papillomavirus infection in low‐risk women in Portland, Oregon
57. The changing prevalence of cervical human papilloma virus infection
58. Persistence of typespecific human papillomavirus infection among cytologically normal women in Portland, Oregon
59. A follow‐up study of patients with cervical dysplasia
60. Behavior of mild cervical dysplasia during long‐term follow‐up
61. Management of woman with mild and moderate cervical dyskaryosis
62. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically
63. Human papillomavirus infection and other risk factors for cervical neoplasia: a case‐control study
64. Human papillomavirus type 16 DNA in cervical smears as a predictor of high grade cervical intraepithelial neoplasia
65. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia
66. Nutritional epidemiology of cervical neoplasia
67. Sexually transmitted agents and cervical neoplasia in Colombia and Spain
68. Reassessment of the morphological continuum of cervical intraepithelial lesions: Does it reflect different stages in the progression to cervical carcinoma?
69. Spontaneous course of cervical precancerous conditions
70. Women with positive cervical smears but without surgical intervention: a follow‐up study
71. Sexual and reproductive risk factors for invasive squamous cell cervical cancer
72. Factors associated with high and low risk of cervical neoplasia
73. A study of epidemiologic factors in carcinoma of the uterine cervix
74. Differences in risk estimations from a hospital and a population‐based case‐control study
75. A study of the aetiology of carcinoma of the cervix uteri
76. Venereal factors in human cervical cancer: evidence from marital clusters
77. Marital and coital factors in cervical cancer
78. Carcinoma of the cervix in Jewish women in Israel, 1960–67: an epidemiological study
79. Adolescent coitus and cervical cancer: associations of related events with increased risk
80. The relationship of coitus to carcinoma of the cervix
81. Risk factors for cervical cancer in Colombia and Spain
82. Human papillomavirus and invasive cancer in Brazil
83. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high‐risk population
84. A study of environmental factors in carcinoma of the cervix
85. Etiologic factors in carcinoma of the cervix
86. Parity as a risk factor for cervical cancer
87. Case‐control study of risk factors for cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections
88. Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia
89. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives
90. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women
91. The male factor in the etiology of cervical cancer among sexually monogamous women
92. Case‐control study of the husbands of women with dysplasia or carcinoma of the cervix uteri
93. Case‐control study of risk factors for cervical neoplasia in Denmark. I. Role of the “male factor” in women with one lifetime sexual partner
94. Male sexual behavior as risk factor in cervical cancer
95. Male influences on cervical cancer risk
96. HPV‐related genital lesions in men
97. Prevalence of human papillomavirus infection in men: comparison of the partners of infected and uninfected women
98. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner
99. Carcinoma of the cervix: an epidemiologic study
100. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of cervical cancer
101. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk
102. Chlamydia trachomatis and cervical neoplasia
103. Association of human papillomavirus and chlamydia infections with incidence cervical neoplasia
104. Multiple infections in cases of cervical cancer from a high‐incidence area in tropical Africa
105. Smoking and cancer of the uterine cervix: hypothesis
106. Cigarette smoking and cancer of the uterine cervix
107. Cigarette smoking and invasive cervical cancer
108. Smoking as a risk factor in cancer of the cervix: additional evidence from a case‐control study
109. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri
110. Smoking as risk factor in cervical neoplasia
111. Cigarette smoking and the risk of cervical neoplasia
112. Smoking and carcinoma in situ of the uterine cervix
113. Risk factors for invasive cervical cancer among Latinas and non‐Latinas in Los Angeles County
114. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer
115. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix
116. Long‐term use of oral contraceptives and risk of invasive cervical cancer
117. Oral contraceptive use and risk of invasive cervical cancer
118. Oral contraceptives and cervical neoplasia
119. Oral contraceptives and cervical cancer
120. The role of contraceptive use in cervical cancer: the Maryland cervical cancer case‐control study
121. Oral contraceptives and cervical cancer risk in Costa Rica: detection bias or causal association?
122. Oral contraceptives and cervical carcinoma in situ in Chile
123. Invasive squamous‐cell cervical carcinoma and combined oral contraceptives: results from a multinational study
124. Oral contraceptive use and adenocarcinoma of cervix
125. Cervical adenocarcinoma and oral contraceptives
126. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County
127. Increased incidence of adenocarcinoma of the cervix in young women in the United States
128. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis
129. Estrogen and progesterone receptors in cervical human papillomavirus related lesions
130. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities
131. Oral contraceptives and cervical carcinoma
132. Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids
133. A case control study into the possible effects of birth control pills on preclinical carcinoma of the cervix
134. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer
135. The spermicide nonoxynol‐9 does not inactivate papillomavirus
136. Chemoprevention trials and surrogate end point biomarkers in the cervix
137. Carcinoma in situ of cervix and sisters
138. Epidemiology of cervical cancer by cell type
139. Familial occurrence of cervical cancer, stages 0‐IV
140. HLA DR‐DQ associations with cervical carcinoma show papillomavirus‐type specificity
141. Viruses and cancer: causal associations
142. Effects of drugs—immunosuppression
143. Increased incidence of malignancy during chronic renal failure
144. Gynecologic malignancies in immunosuppressed organ homograft recipients
145. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women
146. Risk for human papillomavirus infection in women with human immunodeficiency virus induced immunosuppression
147. Colposcopic evaluation of human immunodeficiency virus‐seropositive women
148. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection
149. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer
150. Human T‐cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica
151. Animal papillomaviruses
152. Papillomavirus infections in animals
153. Prospects for cervical cancer vaccines
154. Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection
155. Risk factors for adenocarcinoma of the cervix: a case‐control study
156. Human papillomavirus and endocervical adenocarcinoma
157. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with human‐kind
158. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
159. Human papillomavirus and other influences on survival from cervical cancer in Panama
160. Prophylactic and therapeutic vaccination against a mucosal papillomavirus
161. Uterine cervix